Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning-enhanced identification of fluorophilic interactions for improved SERS detection of PFOA.

Environmental science. Nano·2026
Same author

Multicore SPION Clustering within Poly(amino acid) Corrals for Enhanced MRI Contrast and Drug Release.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Self-Assembled Cysteamine Reporter Ligands for SERS Nitrate Detection in Continuous Flow.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Differential scanning fluorimetry to assess PFAS binding to bovine serum albumin protein.

Scientific reports·2024
Same author

Electric Potential Induced Prevention and Removal of an Algal Biofoulant from Planar SERS Substrates.

Environmental science & technology·2023
Same author

<i>In situ</i> SERS detection of dissolved nitrate on hydrated gold substrates.

Nanoscale advances·2022

Related Experiment Video

Updated: Jun 1, 2026

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation
12:00

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

Stimuli-responsive liposome-nanoparticle assemblies.

Matthew R Preiss1, Geoffrey D Bothun

  • 1Department of Chemical Engineering, Rhode Island Consortium for Nanoscience and Nanotechnology, University of Rhode Island, 16 Greenhouse Road, Kingston, RI 02881, USA. bothun@egr.uri.edu

Expert Opinion on Drug Delivery
|June 14, 2011
PubMed
Summary

Liposome-nanoparticle assemblies (LNAs) merge liposomes and nanoparticles for advanced therapeutics. These novel nanoscale assemblies enable controlled drug release via external stimuli, offering enhanced stability and targeting.

More Related Videos

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Related Experiment Videos

Last Updated: Jun 1, 2026

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation
12:00

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Materials Science

Background:

  • Advanced nanoscale assemblies are crucial for multifaceted therapeutic applications, including targeted drug delivery, in vivo imaging, diagnostics, and enhanced bioavailability.
  • Liposome-nanoparticle assemblies (LNAs) integrate the therapeutic advantages of liposomes with the functional capabilities of nanoparticles, offering a promising platform for next-generation treatments.
  • LNAs can be engineered through various configurations such as encapsulation, decoration, or bilayer-embedment, allowing for tailored structures and functionalities.

Purpose of the Study:

  • To review the current research landscape concerning the design, characterization, and performance of liposome-nanoparticle assemblies (LNAs).
  • To explore the synergistic potential of combining liposomes and nanoparticles within a single assembly for advanced therapeutic applications.
  • To discuss the opportunities and challenges in developing LNAs for stimuli-responsive, controlled drug release.

Main Methods:

  • A comprehensive literature review was conducted on the current state of research regarding liposome-nanoparticle assemblies (LNAs).
  • The review provides an overview of liposomes and nanoparticles in therapeutic contexts.
  • Discussion focuses on the integration of these components for controlled release mechanisms, particularly using light or radiofrequency stimuli.

Main Results:

  • Liposome-nanoparticle assemblies (LNAs) effectively combine the therapeutic benefits of both liposomes and nanoparticles.
  • Liposomes serve to concentrate and shield nanoparticles from the immune system, enhancing their stability and efficacy.
  • Stimuli-responsive nanoparticles within LNAs can be triggered by external fields (e.g., light, radiofrequency) to control the release of therapeutic cargo from the liposome.

Conclusions:

  • LNAs represent a significant advancement in drug delivery, offering a unique platform for nanoparticle-controlled liposomal release.
  • The inherent properties of LNAs facilitate targeted delivery, enhanced stability, and stimuli-responsive therapeutic actions.
  • Further research into the structure-function-performance relationships of LNAs is critical for their future clinical translation and widespread application.